Search Results

There are 16605 results for: content related to: Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome

  1. You have free access to this content
    The use of vasoconstrictors in patients with cirrhosis: Type 1 HRS and beyond

    Hepatology

    Volume 43, Issue 3, March 2006, Pages: 385–394, Richard Moreau and Didier Lebrec

    Article first published online : 22 FEB 2006, DOI: 10.1002/hep.21094

  2. The effect  of  1  month  of  therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study

    Liver International

    Volume 29, Issue 2, February 2009, Pages: 169–174, Puneeta Tandon, Ross T. Tsuyuki, Lesley Mitchell, Michael Hoskinson, Mang M. Ma, Winnie W. Wong, Andrew L. Mason, Klaus Gutfreund and Vincent G. Bain

    Article first published online : 20 MAY 2008, DOI: 10.1111/j.1478-3231.2008.01778.x

  3. You have free access to this content
    Acute kidney injury in cirrhosis

    Hepatology

    Volume 48, Issue 6, December 2008, Pages: 2064–2077, Guadalupe Garcia-Tsao, Chirag R. Parikh and Antonella Viola

    Article first published online : 2 SEP 2008, DOI: 10.1002/hep.22605

  4. You have free access to this content
    Current treatment strategies for hepatorenal syndrome

    Clinical Liver Disease

    Volume 2, Issue 3, June 2013, Pages: 136–139, Elsa Solà, Mónica Guevara and Pere Ginès

    Article first published online : 21 JUN 2013, DOI: 10.1002/cld.209

  5. You have free access to this content
    Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

    Hepatology

    Volume 29, Issue 6, June 1999, Pages: 1690–1697, Paolo Angeli, Roberta Volpin, Giorgio Gerunda, Raffaella Craighero, Paola Roner, Roberto Merenda, Piero Amodio, Antonietta Sticca, Lorenza Caregaro, Alvise Maffei-Faccioli and Angelo Gatta

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510290629

  6. You have free access to this content
    Management of adult patients with ascites due to cirrhosis: An update

    Hepatology

    Volume 49, Issue 6, June 2009, Pages: 2087–2107, Bruce A. Runyon

    Article first published online : 23 JAN 2009, DOI: 10.1002/hep.22853

  7. You have free access to this content
    MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation

    Hepatology

    Volume 41, Issue 6, June 2005, Pages: 1282–1289, Carlo Alessandria, Osman Ozdogan, Mónica Guevara, Tea Restuccia, Wladimiro Jiménez, Vicente Arroyo, Juan Rodés and Pere Ginès

    Article first published online : 15 APR 2005, DOI: 10.1002/hep.20687

  8. Treatment of Hepatorenal Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 10, October 2009, Pages: 1196–1211, Tyree H. Kiser, Robert MacLaren and Douglas N. Fish

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.29.10.1196

  9. You have free access to this content
    Association of AKI With mortality and complications in hospitalized patients with cirrhosis

    Hepatology

    Volume 57, Issue 2, February 2013, Pages: 753–762, Justin M. Belcher, Guadalupe Garcia-Tsao, Arun J. Sanyal, Harjit Bhogal, Joseph K. Lim, Naheed Ansari, Steven G. Coca, Chirag R. Parikh and for the TRIBE-AKI Consortium

    Article first published online : 6 DEC 2012, DOI: 10.1002/hep.25735

  10. You have free access to this content
    Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome

    Hepatology

    Volume 51, Issue 1, January 2010, Pages: 219–226, André Nazar, Gustavo Henrique Pereira, Mónica Guevara, Marta Martín-Llahi, Marie-Noëlle Pepin, Marcella Marinelli, Elsa Solá, María Eugenia Baccaro, Carlos Terra, Vicente Arroyo and Pere Ginès

    Article first published online : 9 SEP 2009, DOI: 10.1002/hep.23283

  11. You have free access to this content
    Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 576–584, Lise L. Gluud, Kurt Christensen, Erik Christensen and Aleksander Krag

    Article first published online : 9 SEP 2009, DOI: 10.1002/hep.23286

  12. Lecture: Hepatorenal Syndrome: Current Concepts

    Portal Hypertension IV: Proceedings of the Fourth Baveno International Consensus Workshop

    Andrés Cárdenas, Pere Ginés, Pages: 201–216, 2007

    Published Online : 16 NOV 2007, DOI: 10.1002/9780470988831.ch8

  13. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study

    Liver International

    Volume 28, Issue 7, August 2008, Pages: 1019–1025, Beate Appenrodt, Andrea Wolf, Frank Grünhage, Jonel Trebicka, Michael Schepke, Christian Rabe, Frank Lammert, Tilman Sauerbruch and J. Heller

    Article first published online : 11 APR 2008, DOI: 10.1111/j.1478-3231.2008.01734.x

  14. You have free access to this content
    Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials

    Hepatology

    Volume 55, Issue 4, April 2012, Pages: 1172–1181, Mauro Bernardi, Paolo Caraceni, Roberta J. Navickis and Mahlon M. Wilkes

    Article first published online : 27 MAR 2012, DOI: 10.1002/hep.24786

  15. You have free access to this content
    Octreotide in hepatorenal syndrome: A randomized, double-blind, placebo-controlled, crossover study

    Hepatology

    Volume 38, Issue 1, July 2003, Pages: 238–243, Gilles Pomier-Layrargues, Sarto C. Paquin, Ziad Hassoun, Michel Lafortune and Albert Tran

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2003.50276

  16. You have free access to this content
    Acute effects of the oral administration of midodrine, an α-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites

    Hepatology

    Volume 28, Issue 4, October 1998, Pages: 937–943, Paolo Angeli, Roberta Volpin, Donatella Piovan, Andrea Bortoluzzi, Raffaella Craighero, Stefania Bottaro, Gian Franco Finucci, Edoardo Casiglia, Antonietta Sticca, Renzo De Toni, Lucia Pavan and A. Gatta

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510280407

  17. You have free access to this content
    Management of hepatorenal syndrome: Another piece of the puzzle

    Hepatology

    Volume 40, Issue 1, July 2004, Pages: 16–18, Pere Ginès, Mónica Guevara M.D and Felix Perez-Villa

    Article first published online : 30 JUN 2004, DOI: 10.1002/hep.20313

  18. Agents for the treatment of portal hypertension

    Pocket Guide to Gastrointestinal Drugs

    Karen L. Krok, Andrés Cárdenas, Pages: 165–178, 2014

    Published Online : 10 JAN 2014, DOI: 10.1002/9781118481530.ch12

  19. Hepatorenal Syndrome in Cirrhosis: Clinical Features, Diagnosis, and Management

    Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment, Second Edition

    Vicente Arroyo, Carlos Terra, Aldo Torre, Pere Ginès, Pages: 341–359, 2007

    Published Online : 25 OCT 2007, DOI: 10.1002/9780470987476.ch28

  20. You have free access to this content
    Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice

    Hepatology

    Volume 51, Issue 1, January 2010, Pages: 237–245, Yosuke Osawa, Ekihiro Seki, Masayuki Adachi, Atsushi Suetsugu, Hiroyasu Ito, Hisataka Moriwaki, Mitsuru Seishima and Masahito Nagaki

    Article first published online : 31 AUG 2009, DOI: 10.1002/hep.23262